APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Disease Aerosol Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pulmonary Disease Aerosol Delivery Devices Industry Growth and Trends Forecast to 2032

28 December 2025118 pages

Choose your research edition.

Industry ResearchPulmonary Disease Aerosol Delivery Devices Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Disease Aerosol Delivery Devices Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Disease Aerosol Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Disease Aerosol Delivery Devices Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Disease Aerosol Delivery Devices Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pulmonary Disease Aerosol Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pulmonary Disease Aerosol Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pulmonary Disease Aerosol Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Disease Aerosol Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmonary Disease Aerosol Delivery Devices include Novartis, Merck, Viatris, GlaxoSmithKline (GSK), AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International and OMRON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pulmonary Disease Aerosol Delivery Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pulmonary Disease Aerosol Delivery Devices market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pulmonary Disease Aerosol Delivery Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pulmonary Disease Aerosol Delivery Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pulmonary Disease Aerosol Delivery Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pulmonary Disease Aerosol Delivery Devices Market by Company

Novartis

Merck

Viatris

GlaxoSmithKline (GSK)

AstraZeneca

Vectura

Teva Pharmaceutical Industries

PARI International

OMRON

Monaghan Medical

Koninklijke Philips

H&T Presspart

Chiesi Farmaceutici

Boehringer Ingelheim

AptarGroup

Pulmonary Disease Aerosol Delivery Devices Segment by Type

Metered- dose Inhalers

Dry-powder Inhalers

Nebulizers

Pulmonary Disease Aerosol Delivery Devices Segment by Application

Asthma

Idiopathic Pulmonary Fibrosis (IPF)

Cystic Fibrosis (CF)

Chronic Obstructive Pulmonary Disease (COPD)

Others

Pulmonary Disease Aerosol Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Disease Aerosol Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Disease Aerosol Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Disease Aerosol Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Disease Aerosol Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pulmonary Disease Aerosol Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Metered- dose Inhalers Table 2. Major Company of Dry-powder Inhalers Table 3. Major Company of Nebulizers Table 4. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 6. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type (2021-2026) Table 7. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 8. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type (2021-2026) Table 9. Global Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 10. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 11. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type (2027-2032) Table 12. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (US$ Million) Table 13. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type (2027-2032) Table 14. Global Pulmonary Disease Aerosol Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 15. North America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 16. North America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 18. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 22. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 25. Pulmonary Disease Aerosol Delivery Devices Industry Trends Table 26. Pulmonary Disease Aerosol Delivery Devices Industry Drivers Table 27. Pulmonary Disease Aerosol Delivery Devices Industry Opportunities and Challenges Table 28. Pulmonary Disease Aerosol Delivery Devices Industry Restraints Table 29. Global Pulmonary Disease Aerosol Delivery Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Company (2021-2026) Table 31. Global Pulmonary Disease Aerosol Delivery Devices Sales by Company (2021-2026) & (K Units) Table 32. Global Pulmonary Disease Aerosol Delivery Devices Sales Share by Company (2021-2026) Table 33. Global Pulmonary Disease Aerosol Delivery Devices Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Pulmonary Disease Aerosol Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Pulmonary Disease Aerosol Delivery Devices Major Company Production Sites and Headquarters Table 36. Global Pulmonary Disease Aerosol Delivery Devices Company, Product Type & Application Table 37. Global Pulmonary Disease Aerosol Delivery Devices Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Pulmonary Disease Aerosol Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Pulmonary Disease Aerosol Delivery Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2021-2026) & (K Units) Table 42. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Region (2021-2026) Table 43. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2021-2026) & (US$ Million) Table 44. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Region (2021-2026) Table 45. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2027-2032) & (K Units) Table 47. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Region (2027-2032) Table 48. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2027-2032) & (US$ Million) Table 49. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Region (2027-2032) Table 50. Global Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 53. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application (2021-2026) Table 54. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 55. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application (2021-2026) Table 56. Global Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 58. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application (2027-2032) Table 59. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (US$ Million) Table 60. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application (2027-2032) Table 61. Global Pulmonary Disease Aerosol Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 62. North America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 63. North America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 65. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 69. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Novartis Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 76. Novartis Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Merck Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 81. Merck Recent Development Table 82. Viatris Company Information Table 83. Viatris Business Overview Table 84. Viatris Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Viatris Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 86. Viatris Recent Development Table 87. GlaxoSmithKline (GSK) Company Information Table 88. GlaxoSmithKline (GSK) Business Overview Table 89. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 91. GlaxoSmithKline (GSK) Recent Development Table 92. AstraZeneca Company Information Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 96. AstraZeneca Recent Development Table 97. Vectura Company Information Table 98. Vectura Business Overview Table 99. Vectura Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Vectura Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 101. Vectura Recent Development Table 102. Teva Pharmaceutical Industries Company Information Table 103. Teva Pharmaceutical Industries Business Overview Table 104. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 106. Teva Pharmaceutical Industries Recent Development Table 107. PARI International Company Information Table 108. PARI International Business Overview Table 109. PARI International Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. PARI International Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 111. PARI International Recent Development Table 112. OMRON Company Information Table 113. OMRON Business Overview Table 114. OMRON Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. OMRON Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 116. OMRON Recent Development Table 117. Monaghan Medical Company Information Table 118. Monaghan Medical Business Overview Table 119. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 121. Monaghan Medical Recent Development Table 122. Koninklijke Philips Company Information Table 123. Koninklijke Philips Business Overview Table 124. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 126. Koninklijke Philips Recent Development Table 127. H&T Presspart Company Information Table 128. H&T Presspart Business Overview Table 129. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 131. H&T Presspart Recent Development Table 132. Chiesi Farmaceutici Company Information Table 133. Chiesi Farmaceutici Business Overview Table 134. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 136. Chiesi Farmaceutici Recent Development Table 137. Boehringer Ingelheim Company Information Table 138. Boehringer Ingelheim Business Overview Table 139. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 141. Boehringer Ingelheim Recent Development Table 142. AptarGroup Company Information Table 143. AptarGroup Business Overview Table 144. AptarGroup Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. AptarGroup Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 146. AptarGroup Recent Development Table 147. North America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 149. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021-2026) Table 150. North America Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 151. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 152. North America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Pulmonary Disease Aerosol Delivery Devices Market Share by Country (2021-2026) Table 155. North America Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Pulmonary Disease Aerosol Delivery Devices Market Share Forecast by Country (2027-2032) Table 157. Europe Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 159. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021-2026) Table 160. Europe Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 161. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Pulmonary Disease Aerosol Delivery Devices Market Share by Country (2021-2026) Table 165. Europe Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Pulmonary Disease Aerosol Delivery Devices Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 169. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 171. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Share by Country (2021-2026) Table 175. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Share Forecast by Country (2027-2032) Table 177. Latin America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 179. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021-2026) Table 180. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 181. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Pulmonary Disease Aerosol Delivery Devices Market Share by Country (2021-2026) Table 185. Latin America Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Pulmonary Disease Aerosol Delivery Devices Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 189. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 191. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Share by Country (2021-2026) Table 195. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Pulmonary Disease Aerosol Delivery Devices Distributors List Table 200. Pulmonary Disease Aerosol Delivery Devices Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Pulmonary Disease Aerosol Delivery Devices Image Figure 2. Global Pulmonary Disease Aerosol Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Disease Aerosol Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Disease Aerosol Delivery Devices Sales (2021-2032) & (K Units) Figure 5. Metered- dose Inhalers Image Figure 6. Global Metered- dose Inhalers Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dry-powder Inhalers Image Figure 8. Global Dry-powder Inhalers Sales YoY Growth (2021-2032) & (K Units) Figure 9. Nebulizers Image Figure 10. Global Nebulizers Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Pulmonary Disease Aerosol Delivery Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Pulmonary Disease Aerosol Delivery Devices Market Share by Type 2025 VS 2032 Figure 13. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 14. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type in 2025 Figure 15. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 16. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type in 2025 Figure 19. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Pulmonary Disease Aerosol Delivery Devices Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Asthma Image Figure 26. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 27. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 28. Global Idiopathic Pulmonary Fibrosis (IPF) Sales YoY Growth (2021-2032) & (K Units) Figure 29. Cystic Fibrosis (CF) Image Figure 30. Global Cystic Fibrosis (CF) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 32. Global Chronic Obstructive Pulmonary Disease (COPD) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Pulmonary Disease Aerosol Delivery Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Pulmonary Disease Aerosol Delivery Devices Market Share by Application 2025 VS 2032 Figure 37. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 38. North America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application in 2025 Figure 39. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 40. Europe Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application in 2025 Figure 43. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Market Share in Value by Application in 2025 Figure 47. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Pulmonary Disease Aerosol Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Pulmonary Disease Aerosol Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Pulmonary Disease Aerosol Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Pulmonary Disease Aerosol Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Pulmonary Disease Aerosol Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pulmonary Disease Aerosol Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Pulmonary Disease Aerosol Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Pulmonary Disease Aerosol Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Pulmonary Disease Aerosol Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pulmonary Disease Aerosol Delivery Devices Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Pulmonary Disease Aerosol Delivery Devices Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Applications
  • Asthma
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Cystic Fibrosis (CF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others
Companies covered
  • Novartis
  • Merck
  • Viatris
  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Vectura
  • Teva Pharmaceutical Industries
  • PARI International
  • OMRON
  • Monaghan Medical
  • Koninklijke Philips
  • H&T Presspart
  • Chiesi Farmaceutici
  • Boehringer Ingelheim
  • AptarGroup

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pulmonary Disease Aerosol Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pulmonary Disease Aerosol Delivery Devices Market by Type
  6. 1.3.1 Metered- dose Inhalers
  7. 1.3.2 Dry-powder Inhalers
  8. 1.3.3 Nebulizers
  9. 1.4 Global Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  10. 1.4.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Pulmonary Disease Aerosol Delivery Devices Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Pulmonary Disease Aerosol Delivery Devices Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pulmonary Disease Aerosol Delivery Devices Industry Trends
  2. 2.2 Pulmonary Disease Aerosol Delivery Devices Industry Drivers
  3. 2.3 Pulmonary Disease Aerosol Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Pulmonary Disease Aerosol Delivery Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Pulmonary Disease Aerosol Delivery Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Pulmonary Disease Aerosol Delivery Devices Price (2021-2026)
  4. 3.4 Global Pulmonary Disease Aerosol Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmonary Disease Aerosol Delivery Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Pulmonary Disease Aerosol Delivery Devices Company, Product Type & Application
  7. 3.7 Global Pulmonary Disease Aerosol Delivery Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmonary Disease Aerosol Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmonary Disease Aerosol Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmonary Disease Aerosol Delivery Devices Tier 1, Tier 2, and Tier 3
4 Pulmonary Disease Aerosol Delivery Devices Regional Status and Outlook
  1. 4.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pulmonary Disease Aerosol Delivery Devices Historic Market Size by Region
  3. 4.2.1 Global Pulmonary Disease Aerosol Delivery Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pulmonary Disease Aerosol Delivery Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pulmonary Disease Aerosol Delivery Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pulmonary Disease Aerosol Delivery Devices Forecasted Market Size by Region
  7. 4.3.1 Global Pulmonary Disease Aerosol Delivery Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pulmonary Disease Aerosol Delivery Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pulmonary Disease Aerosol Delivery Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pulmonary Disease Aerosol Delivery Devices by Application
  1. 5.1 Pulmonary Disease Aerosol Delivery Devices Market by Application
  2. 5.1.1 Asthma
  3. 5.1.2 Idiopathic Pulmonary Fibrosis (IPF)
  4. 5.1.3 Cystic Fibrosis (CF)
  5. 5.1.4 Chronic Obstructive Pulmonary Disease (COPD)
  6. 5.1.5 Others
  7. 5.2 Global Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  8. 5.2.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Pulmonary Disease Aerosol Delivery Devices Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Pulmonary Disease Aerosol Delivery Devices Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Viatris
  14. 6.3.1 Viatris Company Information
  15. 6.3.2 Viatris Business Overview
  16. 6.3.3 Viatris Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viatris Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  18. 6.3.5 Viatris Recent Developments
  19. 6.4 GlaxoSmithKline (GSK)
  20. 6.4.1 GlaxoSmithKline (GSK) Company Information
  21. 6.4.2 GlaxoSmithKline (GSK) Business Overview
  22. 6.4.3 GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  24. 6.4.5 GlaxoSmithKline (GSK) Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Vectura
  32. 6.6.1 Vectura Company Information
  33. 6.6.2 Vectura Business Overview
  34. 6.6.3 Vectura Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vectura Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  36. 6.6.5 Vectura Recent Developments
  37. 6.7 Teva Pharmaceutical Industries
  38. 6.7.1 Teva Pharmaceutical Industries Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Recent Developments
  43. 6.8 PARI International
  44. 6.8.1 PARI International Company Information
  45. 6.8.2 PARI International Business Overview
  46. 6.8.3 PARI International Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PARI International Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  48. 6.8.5 PARI International Recent Developments
  49. 6.9 OMRON
  50. 6.9.1 OMRON Company Information
  51. 6.9.2 OMRON Business Overview
  52. 6.9.3 OMRON Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 OMRON Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  54. 6.9.5 OMRON Recent Developments
  55. 6.10 Monaghan Medical
  56. 6.10.1 Monaghan Medical Company Information
  57. 6.10.2 Monaghan Medical Business Overview
  58. 6.10.3 Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  60. 6.10.5 Monaghan Medical Recent Developments
  61. 6.11 Koninklijke Philips
  62. 6.11.1 Koninklijke Philips Company Information
  63. 6.11.2 Koninklijke Philips Business Overview
  64. 6.11.3 Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  66. 6.11.5 Koninklijke Philips Recent Developments
  67. 6.12 H&T Presspart
  68. 6.12.1 H&T Presspart Company Information
  69. 6.12.2 H&T Presspart Business Overview
  70. 6.12.3 H&T Presspart Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 H&T Presspart Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  72. 6.12.5 H&T Presspart Recent Developments
  73. 6.13 Chiesi Farmaceutici
  74. 6.13.1 Chiesi Farmaceutici Company Information
  75. 6.13.2 Chiesi Farmaceutici Business Overview
  76. 6.13.3 Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  78. 6.13.5 Chiesi Farmaceutici Recent Developments
  79. 6.14 Boehringer Ingelheim
  80. 6.14.1 Boehringer Ingelheim Company Information
  81. 6.14.2 Boehringer Ingelheim Business Overview
  82. 6.14.3 Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  84. 6.14.5 Boehringer Ingelheim Recent Developments
  85. 6.15 AptarGroup
  86. 6.15.1 AptarGroup Company Information
  87. 6.15.2 AptarGroup Business Overview
  88. 6.15.3 AptarGroup Pulmonary Disease Aerosol Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AptarGroup Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  90. 6.15.5 AptarGroup Recent Developments
7 North America by Country
  1. 7.1 North America Pulmonary Disease Aerosol Delivery Devices Sales by Country
  2. 7.1.1 North America Pulmonary Disease Aerosol Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  6. 7.2.1 North America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country
  2. 8.1.1 Europe Pulmonary Disease Aerosol Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  6. 8.2.1 Europe Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Country
  2. 9.1.1 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pulmonary Disease Aerosol Delivery Devices Sales by Country
  2. 10.1.1 South America Pulmonary Disease Aerosol Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  6. 10.2.1 South America Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country
  2. 11.1.1 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pulmonary Disease Aerosol Delivery Devices Value Chain Analysis
  2. 12.1.1 Pulmonary Disease Aerosol Delivery Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pulmonary Disease Aerosol Delivery Devices Production Mode & Process
  7. 12.2 Pulmonary Disease Aerosol Delivery Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pulmonary Disease Aerosol Delivery Devices Distributors
  10. 12.2.3 Pulmonary Disease Aerosol Delivery Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst